-
Jan 12, 2025 | 
mdpi.com | Lu Jiao |Zejun Wang |Yingying Yu |Xiaoting Duan
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Dec 5, 2024 | 
mdpi.com | Jiahe Tian |Shida Pan |Yilin Wang |Yingying Yu
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Oct 20, 2024 | 
mdpi.com | Shanshan Feng |Wenwen Xiao |Yingying Yu |Guangfeng Liu
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Oct 1, 2024 | 00284-5?rss=yes&sz=64)
cell.com | Zhejiang Province |Liang Tao |Xinquan Yang |Chaodong Ge |Peng Zhang |Xingbo Xu | +9 more
KeywordsMASHiron chelatoriron metabolismferroptosisFerroTerminator1FOT1ACSL4c-MYCserum ferritinliver diseaseIntroductionThe prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD),11. Lazarus, J.V. ∙ Mark, H.E. ∙ Allen, A.M. ... A global research priority agenda to advance public health responses to fatty liver diseaseJ. Hepatol.
-
Jun 26, 2024 | 
mdpi.com | Yingying Yu |Yaxi Zhang |Yurong Zhou |Jiajia Xia
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Jun 4, 2024 | 
onlinelibrary.wiley.com | Qian Gong |Nano-Bionics Chinese Academy |Power Engineering Lanzhou |Yingying Yu
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adfm202406550-sup-0001-SuppMat.docx5.4 MB Supporting Information adfm202406550-sup-0002-MovieS1.mp45.7 MB Supplemental Movie 1 adfm202406550-sup-0003-MovieS2.mp433 MB Supplemental Movie 2 adfm202406550-sup-0004-MovieS3.mp411.2 MB Supplemental Movie 3 References 1, , , , , , , , , , , , , , , , Nature 2024, 626, 999. 2, Nat. Mater. 2011, 10, 817.
-
May 31, 2024 | 
mdpi.com | Yingying Yu |He Wang |Yuchi Zhang |Ping Kou
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
May 21, 2024 | 
mdpi.com | Jiahe Tian |Yingying Yu |Yaoru Song |Shida Pan
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Apr 2, 2024 | 
mdpi.com | Marco F. D’Elia |Yingying Yu |Madeleine A. Ehweiner |Melvin Renggli
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Mar 27, 2024 | 
onlinelibrary.wiley.com | Yingying Yu |Yunxing Su |Yutong Liu |Zhiting Lin
Graphical Abstract Iron-Refractory Anemia In article number 2307022, Yatrik M. Shah, Junxia Min, Fudi Wang, and co-workers show hypoxia and the HIF-PH inhibitor as anemia novel therapies through Hif2α (phoenix) mediated transcriptional upregulation of Fpn (dragon) in the intestinal villi (mountains). Increased Fpn transports more iron into the circulation (depicted by the dragon's breath), thereby treating anemia (red blood cell).
